Moderna Collaboration and License Agreement (Tables)

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Estimated Revenue Expected to be Recognized in The Future Related to Performance Obligations

The following table includes estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied as of September 30, 2023 (in thousands):

	Transaction price unsatisfied
Performance obligations:
Research and development	$	52,333
Option rights	45,000
Total performance obligations	$	97,333

Schedule of Changes in Deferred Revenue

The following table summarizes the changes in deferred revenue (in thousands):

	Nine Months Ended September 30,
	2023		2022
Balance at the beginning of the period	$	47,459	$	—
Deferral of revenue	9,356		52,333
Recognition of unearned revenue	(10,630)		(6,103)
Balance at the end of the period	$	46,185	$	46,230